Baron-Stefaniak Joanna, Götz Viola, Allhutter Andreas, Schiefer Judith, Hamp Thomas, Faybik Peter, Berlakovich Gabriela, Baron David M, Plöchl Walter
From the *Department of Anesthesia, General Intensive Care and Pain Management, and †Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria.
Anesth Analg. 2017 Sep;125(3):783-789. doi: 10.1213/ANE.0000000000002250.
Sevoflurane is a volatile anesthetic commonly used to maintain anesthesia in patients with end-stage liver disease (ESLD) undergoing orthotopic liver transplantation (OLT). Growing evidence suggests that patients with ESLD have decreased anesthetic requirements compared to patients with preserved liver function. The potency of volatile anesthetics is expressed as the minimum alveolar concentration (MAC). In this prospective, blinded study, we compared the MAC of sevoflurane among patients with ESLD undergoing OLT and patients with normal liver function undergoing major abdominal surgery.
After propofol-induced anesthesia, the MAC of sevoflurane was assessed by evaluating motor response to initial skin incision in patients undergoing OLT and in patients with normal liver function undergoing major abdominal surgery. The MAC was determined using Dixon "up-and-down" method and compared between groups. In addition, the bispectral index was documented immediately before and after skin incision.
Twenty patients undergoing OLT and 20 control patients were included in the study. The MAC of sevoflurane in patients undergoing OLT was 1.3% (95% confidence interval [CI], 1.1-1.4). In comparison, the MAC of sevoflurane in patients with normal liver function was 1.7% (95% CI, 1.6-1.9), equal to a relative reduction of the MAC in patients with ESLD of 26% (95% CI, 14-39). The bispectral index was higher in patients with ESLD than in control patients at 3 minutes before (47 [95% CI, 40-53] vs 35 [95% CI, 31-40], P = .011), 1 minute before (48 [95% CI, 42-54] vs 37 [95% CI, 33-43], P = .03), and 1 minute after skin incision (57 [95% CI, 50-64] vs 41 [95% CI, 36-47], P < .001).
Our results suggest that the MAC of sevoflurane is lower in patients with ESLD than in patients with normal liver function after propofol-induced anesthesia. However, as we did not measure propofol concentrations at the time of skin incision, the difference in MAC should be interpreted with caution given that residual propofol may have been present at the time of skin incision.
七氟醚是一种挥发性麻醉剂,常用于原位肝移植(OLT)的终末期肝病(ESLD)患者的麻醉维持。越来越多的证据表明,与肝功能正常的患者相比,ESLD患者的麻醉需求降低。挥发性麻醉剂的效能以最低肺泡浓度(MAC)表示。在这项前瞻性、双盲研究中,我们比较了接受OLT的ESLD患者和接受腹部大手术的肝功能正常患者的七氟醚MAC。
在丙泊酚诱导麻醉后,通过评估OLT患者和接受腹部大手术的肝功能正常患者对初始皮肤切口的运动反应来评估七氟醚的MAC。使用Dixon“上下”法确定MAC并在组间进行比较。此外,在皮肤切口前后立即记录脑电双频指数。
本研究纳入了20例接受OLT的患者和20例对照患者。接受OLT的患者七氟醚MAC为1.3%(95%置信区间[CI],1.1 - 1.4)。相比之下,肝功能正常患者的七氟醚MAC为1.7%(95%CI,1.6 - 1.9),相当于ESLD患者的MAC相对降低26%(95%CI,14 - 39)。在皮肤切口前3分钟(47[95%CI,40 - 53]对35[95%CI,31 - 40],P = 0.011)、前1分钟(48[95%CI,42 - 54]对37[95%CI,33 - 43],P = 0.03)以及皮肤切口后1分钟(57[95%CI,50 - 64]对41[95%CI,36 - 47],P < 0.001),ESLD患者的脑电双频指数高于对照患者。
我们的结果表明,丙泊酚诱导麻醉后,ESLD患者的七氟醚MAC低于肝功能正常的患者。然而,由于我们在皮肤切口时未测量丙泊酚浓度,鉴于皮肤切口时可能存在残余丙泊酚,MAC的差异应谨慎解释。